(BAS) BASF SE - Overview
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE000BASF111
Stock:
Total Rating 46
Risk 82
Buy Signal -0.05
| Risk 5d forecast | |
|---|---|
| Volatility | 27.0% |
| Relative Tail Risk | -5.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.09 |
| Alpha | -8.81 |
| Character TTM | |
|---|---|
| Beta | 0.708 |
| Beta Downside | 1.341 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.19% |
| CAGR/Max DD | 0.35 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 146.0588
Description: BAS BASF SE
BASF SE operates as a chemical company worldwide. It operates through six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions. The Chemicals segment provides petrochemicals and intermediates. The Materials segment offers advanced materials and their precursors for applications and systems comprising isocyanates, polyamides, and inorganic basic products, as well as specialties for plastics and plastics processing industries. The Industrial Solutions segment develops and markets ingredients and additives for industrial applications, such as polymer dispersions, resins, additives, electronic materials, and antioxidants for automotive, plastics and adhesives, paints and coatings, construction, electronics, paper coatings, and energy and resources industries. The Surface Technologies segment provides catalysts, battery materials, automotive OEM and refinish coatings, surface treatment, and precious and base metal services for the automotive and chemical industries. The Nutrition & Care segment offers ingredients for consumer applications in the areas of nutrition, home, and personal care applications; and serves the food and feed producers, pharmaceutical, cosmetics, detergents, and cleaner industries, as well as fast-moving consumer goods sector. The Agricultural Solutions segment provides seeds and traits, and seed treatment products; fungicides, herbicides, insecticides, and biological crop protection products; and digital solutions. The company engages in engineering and other; rental and leasing; and commodity trading activities. BASF SE was founded in 1865 and is headquartered in Ludwigshafen am Rhein, Germany.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 273.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -1.89 > 1.0 |
| NWC/Revenue: 25.00% < 20% (prev 22.57%; Δ 2.43% < -1%) |
| CFO/TA 0.07 > 3% & CFO 5.43b > Net Income 273.0m |
| Net Debt (20.92b) to EBITDA (7.24b): 2.89 < 3 |
| Current Ratio: 1.92 > 1.5 & < 3 |
| Outstanding Shares: last quarter (892.5m) vs 12m ago 0.0% < -2% |
| Gross Margin: 25.75% > 18% (prev 0.26%; Δ 2549 % > 0.5%) |
| Asset Turnover: 81.33% > 50% (prev 82.25%; Δ -0.92% > 0%) |
| Interest Coverage Ratio: 2.26 > 6 (EBITDA TTM 7.24b / Interest Expense TTM 1.14b) |
Altman Z'' 3.59
| A: 0.21 (Total Current Assets 33.09b - Total Current Liabilities 17.25b) / Total Assets 76.44b |
| B: 0.39 (Retained Earnings 29.91b / Total Assets 76.44b) |
| C: 0.03 (EBIT TTM 2.58b / Avg Total Assets 77.90b) |
| D: 0.70 (Book Value of Equity 29.62b / Total Liabilities 42.53b) |
| Altman-Z'' Score: 3.59 = A |
Beneish M -3.26
| DSRI: 0.93 (Receivables 10.26b/11.37b, Revenue 63.35b/65.27b) |
| GMI: 0.99 (GM 25.75% / 25.54%) |
| AQI: 0.87 (AQ_t 0.24 / AQ_t-1 0.28) |
| SGI: 0.97 (Revenue 63.35b / 65.27b) |
| TATA: -0.07 (NI 273.0m - CFO 5.43b) / TA 76.44b) |
| Beneish M-Score: -3.26 (Cap -4..+1) = AA |
What is the price of BAS shares?
As of March 01, 2026, the stock is trading at EUR 48.70 with a total of 5,423,419 shares traded.
Over the past week, the price has changed by -0.39%, over one month by +5.64%, over three months by +8.46% and over the past year by +5.20%.
Over the past week, the price has changed by -0.39%, over one month by +5.64%, over three months by +8.46% and over the past year by +5.20%.
Is BAS a buy, sell or hold?
BASF SE has no consensus analysts rating.
What are the forecasts/targets for the BAS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 49.8 | 2.3% |
| Analysts Target Price | - | - |
BAS Fundamental Data Overview February 28, 2026
Market Cap USD = 52.44b (44.32b EUR * 1.1832 EUR.USD)
P/E Trailing = 146.0588
P/E Forward = 14.7493
P/S = 0.6893
P/B = 1.2211
P/EG = 0.8976
Revenue TTM = 63.35b EUR
EBIT TTM = 2.58b EUR
EBITDA TTM = 7.24b EUR
Long Term Debt = 18.93b EUR (from longTermDebt, last quarter)
Short Term Debt = 3.85b EUR (from shortTermDebt, last quarter)
Debt = 22.78b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 20.92b EUR (from netDebt column, last quarter)
Enterprise Value = 65.25b EUR (44.32b + Debt 22.78b - CCE 1.86b)
Interest Coverage Ratio = 2.26 (Ebit TTM 2.58b / Interest Expense TTM 1.14b)
EV/FCF = 218.9x (Enterprise Value 65.25b / FCF TTM 298.0m)
FCF Yield = 0.46% (FCF TTM 298.0m / Enterprise Value 65.25b)
FCF Margin = 0.47% (FCF TTM 298.0m / Revenue TTM 63.35b)
Net Margin = 0.43% (Net Income TTM 273.0m / Revenue TTM 63.35b)
Gross Margin = 25.75% ((Revenue TTM 63.35b - Cost of Revenue TTM 47.04b) / Revenue TTM)
Gross Margin QoQ = 22.06% (prev 26.50%)
Tobins Q-Ratio = 0.85 (Enterprise Value 65.25b / Total Assets 76.44b)
Interest Expense / Debt = 1.16% (Interest Expense 264.0m / Debt 22.78b)
Taxrate = 29.77% (616.0m / 2.07b)
NOPAT = 1.81b (EBIT 2.58b * (1 - 29.77%))
Current Ratio = 1.92 (Total Current Assets 33.09b / Total Current Liabilities 17.25b)
Debt / Equity = 0.70 (Debt 22.78b / totalStockholderEquity, last quarter 32.76b)
Debt / EBITDA = 2.89 (Net Debt 20.92b / EBITDA 7.24b)
Debt / FCF = 70.21 (Net Debt 20.92b / FCF TTM 298.0m)
Total Stockholder Equity = 34.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.35% (Net Income 273.0m / Total Assets 76.44b)
RoE = 0.80% (Net Income TTM 273.0m / Total Stockholder Equity 34.20b)
RoCE = 4.85% (EBIT 2.58b / Capital Employed (Equity 34.20b + L.T.Debt 18.93b))
RoIC = 3.14% (NOPAT 1.81b / Invested Capital 57.66b)
WACC = 5.91% (E(44.32b)/V(67.11b) * Re(8.53%) + D(22.78b)/V(67.11b) * Rd(1.16%) * (1-Tc(0.30)))
Discount Rate = 8.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.01%
[DCF] Terminal Value 83.03% ; FCFF base≈903.2m ; Y1≈686.7m ; Y5≈420.3m
[DCF] Fair Price = N/A (negative equity: EV 12.99b - Net Debt 20.92b = -7.94b; debt exceeds intrinsic value)
EPS Correlation: -14.80 | EPS CAGR: -38.41% | SUE: 0.07 | # QB: 0
Revenue Correlation: -85.14 | Revenue CAGR: -8.23% | SUE: -0.17 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.71 | Chg7d=-0.145 | Chg30d=-0.145 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=2.54 | Chg7d=-0.014 | Chg30d=-0.024 | Revisions Net=-3 | Growth EPS=-10.0% | Growth Revenue=+0.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.8% (Discount Rate 8.5% - Earnings Yield 0.7%)
[Growth] Growth Spread = -23.2% (Analyst -15.3% - Implied 7.8%)
P/E Trailing = 146.0588
P/E Forward = 14.7493
P/S = 0.6893
P/B = 1.2211
P/EG = 0.8976
Revenue TTM = 63.35b EUR
EBIT TTM = 2.58b EUR
EBITDA TTM = 7.24b EUR
Long Term Debt = 18.93b EUR (from longTermDebt, last quarter)
Short Term Debt = 3.85b EUR (from shortTermDebt, last quarter)
Debt = 22.78b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 20.92b EUR (from netDebt column, last quarter)
Enterprise Value = 65.25b EUR (44.32b + Debt 22.78b - CCE 1.86b)
Interest Coverage Ratio = 2.26 (Ebit TTM 2.58b / Interest Expense TTM 1.14b)
EV/FCF = 218.9x (Enterprise Value 65.25b / FCF TTM 298.0m)
FCF Yield = 0.46% (FCF TTM 298.0m / Enterprise Value 65.25b)
FCF Margin = 0.47% (FCF TTM 298.0m / Revenue TTM 63.35b)
Net Margin = 0.43% (Net Income TTM 273.0m / Revenue TTM 63.35b)
Gross Margin = 25.75% ((Revenue TTM 63.35b - Cost of Revenue TTM 47.04b) / Revenue TTM)
Gross Margin QoQ = 22.06% (prev 26.50%)
Tobins Q-Ratio = 0.85 (Enterprise Value 65.25b / Total Assets 76.44b)
Interest Expense / Debt = 1.16% (Interest Expense 264.0m / Debt 22.78b)
Taxrate = 29.77% (616.0m / 2.07b)
NOPAT = 1.81b (EBIT 2.58b * (1 - 29.77%))
Current Ratio = 1.92 (Total Current Assets 33.09b / Total Current Liabilities 17.25b)
Debt / Equity = 0.70 (Debt 22.78b / totalStockholderEquity, last quarter 32.76b)
Debt / EBITDA = 2.89 (Net Debt 20.92b / EBITDA 7.24b)
Debt / FCF = 70.21 (Net Debt 20.92b / FCF TTM 298.0m)
Total Stockholder Equity = 34.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.35% (Net Income 273.0m / Total Assets 76.44b)
RoE = 0.80% (Net Income TTM 273.0m / Total Stockholder Equity 34.20b)
RoCE = 4.85% (EBIT 2.58b / Capital Employed (Equity 34.20b + L.T.Debt 18.93b))
RoIC = 3.14% (NOPAT 1.81b / Invested Capital 57.66b)
WACC = 5.91% (E(44.32b)/V(67.11b) * Re(8.53%) + D(22.78b)/V(67.11b) * Rd(1.16%) * (1-Tc(0.30)))
Discount Rate = 8.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.01%
[DCF] Terminal Value 83.03% ; FCFF base≈903.2m ; Y1≈686.7m ; Y5≈420.3m
[DCF] Fair Price = N/A (negative equity: EV 12.99b - Net Debt 20.92b = -7.94b; debt exceeds intrinsic value)
EPS Correlation: -14.80 | EPS CAGR: -38.41% | SUE: 0.07 | # QB: 0
Revenue Correlation: -85.14 | Revenue CAGR: -8.23% | SUE: -0.17 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.71 | Chg7d=-0.145 | Chg30d=-0.145 | Revisions Net=-1 | Analysts=2
EPS next Year (2026-12-31): EPS=2.54 | Chg7d=-0.014 | Chg30d=-0.024 | Revisions Net=-3 | Growth EPS=-10.0% | Growth Revenue=+0.2%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.8% (Discount Rate 8.5% - Earnings Yield 0.7%)
[Growth] Growth Spread = -23.2% (Analyst -15.3% - Implied 7.8%)